Form 4: Praxis Precision Medicines CFO Timothy Edwin Kelly Reports Stock Acquisition

Timothy Edwin Kelly, CFO of Praxis Precision Medicines, reports acquiring 606 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• On May 14, 2024, Timothy Edwin Kelly, the Chief Financial Officer of Praxis Precision Medicines, Inc., acquired 606 shares of common stock.
• The shares were purchased at a price of $12.368 per share.
• The acquisition was made through the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan.
• Following the transaction, Kelly directly owns 4,340 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a standard transaction. It doesn't indicate positive or negative performance, just a routine acquisition of stock.

Positives

• The acquisition of shares through the Employee Stock Purchase Plan demonstrates the CFO's investment in the company's stock.
• Increased ownership aligns the CFO's interests with those of other shareholders.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates the CFO's participation in the company's employee stock purchase plan.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence as it shows the CFO's investment in the company.

Key Dates